Kimberley Elting, Chief Authorized and Growth Officer for Orthofix, Appointed to Lead International Orthopedics Enterprise
April 8, 2022
LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a worldwide medical gadget firm with a backbone and orthopedics focus, in the present day introduced a management transition for its Orthopedics Enterprise Unit. Kimberley Elting, at present Chief Authorized and Growth Officer for Orthofix, will turn out to be the President of the International Orthopedics enterprise efficient in the present day. On this position, Elting succeeds Paul Gonsalves, who’s leaving the corporate to pursue different alternatives.
“With greater than 25 years within the medical gadget house, a observe document of success at Orthofix, and a demonstrated ardour for our Orthopedics enterprise, Kim will carry sturdy management and significant perspective to this enterprise,” mentioned Orthofix President and CEO Jon Serbousek. “We have now made important investments to construct the Orthopedics Enterprise unit and we really feel assured that she is the best particular person to guide this group to proceed to drive progress on this sector of our enterprise.”
Elting has important expertise within the medical gadget product life cycle, supporting analysis and improvement and commercialization, and main enterprise improvement initiatives that strengthened natural and inorganic firm progress. Her management has resulted within the profitable acquisition of firms and applied sciences that develop the Orthofix portfolio of options, together with the M6-C™ synthetic cervical disc that mimics the pure movement of a local disc, the Fitbone inner limb lengthening system that corrects limb differentials, important enlargement of our biologics portfolio, and key investments in differentiated applied sciences equivalent to nView medical and Neo Medical. In the course of the course of the final 5 years at Orthofix, she has led many features at Orthofix together with Regulatory and High quality, Company Communications, and Enterprise Growth, along with the Authorized group. Within the coming months she’s going to transition her authorized, enterprise improvement and company communications duties to new leaders.
“The Orthopedics enterprise was the inspiration for Orthofix over forty years in the past when this firm was began in Verona, Italy, and it has a protracted historical past of offering significant merchandise and life-changing affected person options to orthopedic surgeons world-wide,” mentioned Elting. “I look ahead to working with this gifted group as we proceed to innovate and produce to market differentiated merchandise and options for pediatric and grownup deformity correction and limb reconstruction, serving to ship on our dedication to enhance affected person mobility.”
Elting joined the Orthofix Management group as Chief Authorized Officer in September 2016, was named Chief Authorized and Administrative Officer in 2017, and Chief Authorized and Growth Officer in 2020. A seasoned govt, she has a powerful background within the medical gadget business. Earlier than coming to Orthofix, Elting served as Basic Counsel and Vice President Company Affairs at TriVascular Applied sciences, Inc. On this position, she led the authorized, compliance, human assets (HR) and authorities affairs features for the corporate. Previous to this, Elting served in varied roles of accelerating duty with St. Jude Medical together with Basic Counsel and Vice President of HR and Health Coverage for the Neuromodulation Division. Elting beforehand was a companion on the Jones Day legislation agency. A graduate of Ithaca Faculty, Elting earned her Legislation Diploma from the College of Denver and an LL.M. in Health Legislation from Loyola College Chicago.
Orthofix Medical Inc. is a worldwide medical gadget firm with a backbone and orthopedics focus. The Firm’s mission is to ship revolutionary, quality-driven options whereas partnering with well being care professionals to enhance affected person mobility. Headquartered in Lewisville, Texas, Orthofix’s backbone and orthopedics merchandise are distributed in additional than 60 international locations through the Firm’s gross sales representatives and distributors. For extra info, please go to Orthofix.com.
This communication incorporates forward-looking statements inside the that means of Part 21E of the Securities Trade Act of 1934, as amended, and Part 27A of the Securities Act of 1933, as amended, regarding our enterprise and monetary outlook, that are based mostly on our present beliefs, assumptions, expectations, estimates, forecasts and projections. In some instances, you possibly can establish forward-looking statements by terminology equivalent to “could,” “will,” “ought to,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “initiatives,” “intends,” “predicts,” “potential,” or “proceed” or different comparable terminology. These forward-looking statements should not ensures of our future efficiency and contain dangers, uncertainties, estimates and assumptions which might be tough to foretell, together with the dangers described in Half I, Merchandise 1A underneath the heading Threat Components in our Annual Report on Type 10-Okay for the 12 months ended December 31, 2021 (the “2021 Type 10-Okay”).
This checklist of dangers, uncertainties and different components isn’t full. We talk about a few of these issues extra absolutely, in addition to sure danger components that would have an effect on our enterprise, monetary situation, outcomes of operations, and prospects, in reviews we file from time-to-time with the SEC, which can be found to learn at www.sec.gov. All or any forward-looking statements that we make could develop into flawed (because of inaccurate assumptions that we make or in any other case), and our precise outcomes and outcomes could differ materially from these expressed in these forward-looking statements. You shouldn’t place undue reliance on any of those forward-looking statements. Additional, any forward-looking assertion speaks solely as of the date hereof, until it’s particularly in any other case acknowledged to be made as of a special date. We undertake no obligation to replace, and expressly disclaim any responsibility to replace, our forward-looking statements, whether or not on account of circumstances or occasions that come up after the date hereof, new info, or in any other case
Tel 214 937 3190
Tel 214 937 2529